Stockreport

Regen BioPharma, Inc. Expands Vision for Phase 1 Clinical Trial of HemaXellerate™

Regen Biopharma, Inc. Common  (RGBP) 
NASDAQ:AMEX Investor Relations: regenbiopharmainc.com/investor-relations.html
PDF Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today [Read more]